{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:36:37Z","timestamp":1790861797490,"version":"4.1.0"},"reference-count":26,"publisher":"Hindawi Limited","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2434,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1111\/j.1600-0404.2008.01062.x","type":"journal-article","created":{"date-parts":[[2008,7,8]],"date-time":"2008-07-08T15:49:38Z","timestamp":1215532178000},"page":"55-60","source":"Crossref","is-referenced-by-count":18,"title":["Retention rates of new antiepileptic drugs in localization-related epilepsy: a single-center study"],"prefix":"10.1155","volume":"119","author":[{"given":"J.","family":"Peltola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Peltola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Auvinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Raitanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Ker\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","reference":[{"key":"10.1111\/j.1600-0404.2008.01062.x-BIB1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/01.wco.0000218235.67840.82","article-title":"Modern antiepileptic drugs: guidelines and beyond","volume":"19","author":"Hitiris","year":"2006","journal-title":"Curr Opin Neurol"},{"issue":"Suppl","key":"10.1111\/j.1600-0404.2008.01062.x-BIB2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1600-0404.2005.00505.x","article-title":"New antiepileptic drugs in practice - how do they perform in the real world?","volume":"181","author":"Sander","year":"2005","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.2008.01062.x-BIB3","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001901","article-title":"Levetiracetam add-on for drug-resistant localization related (partial) epilepsy","author":"Chaisewikul","year":"2001","journal-title":"Coch Database System Rev"},{"key":"10.1111\/j.1600-0404.2008.01062.x-BIB4","article-title":"Topiramate for drug-resistant partial epilepsy","author":"Jette","year":"2000","journal-title":"Coch Database System Rev"},{"key":"10.1111\/j.1600-0404.2008.01062.x-BIB5","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001908","article-title":"Tiagabine add-on for drug-resistant partial epilepsy","author":"Pereira","year":"2002","journal-title":"Coch Database System Rev"},{"key":"10.1111\/j.1600-0404.2008.01062.x-BIB6","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1528-1157.1997.tb01251.x","article-title":"The new antiepileptic drugs: a systematic review of their efficacy and tolerability","volume":"38","author":"Marson","year":"1997","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.2008.01062.x-BIB7","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1111\/j.1528-1157.2000.tb00165.x","article-title":"Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy","volume":"41","author":"Lhatoo","year":"2000","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.2008.01062.x-BIB8","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.seizure.2004.10.002","article-title":"Retention rate of oxcarbazepine monotherapy in an unselected population of adult epileptics","volume":"14","author":"Rainesalo","year":"2005","journal-title":"Seizure"},{"key":"10.1111\/j.1600-0404.2008.01062.x-BIB9","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.seizure.2007.08.001","article-title":"Seizure-freedom with combination therapy in localization-related epilepsy","volume":"17","author":"Peltola","year":"2008","journal-title":"Seizure"},{"key":"10.1111\/j.1600-0404.2008.01062.x-BIB10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","article-title":"Commission on Classification and Terminology of the International League against Epilepsy","volume":"30","author":"Proposal for revised classification of epilepsies, epileptic syndromes","year":"1989","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.2008.01062.x-BIB11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete data","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Statist Assoc"},{"key":"10.1111\/j.1600-0404.2008.01062.x-BIB12","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/j.1528-1157.1999.tb02017.x","article-title":"The long-term use of gabapentin, lamotrigine, and vigabatrin in patients with chronic epilepsy","volume":"40","author":"Wong","year":"1999","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.2008.01062.x-BIB13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1053\/seiz.2000.0403","article-title":"A comparison of four new antiepileptic medications","volume":"9","author":"Collins","year":"2000","journal-title":"Seizure"},{"key":"10.1111\/j.1600-0404.2008.01062.x-BIB14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1059-1311(96)80019-7","article-title":"A survey comparing lamotrigine and vigabatrin in everyday clinical practice","volume":"5","author":"Schapel","year":"1996","journal-title":"Seizure"},{"key":"10.1111\/j.1600-0404.2008.01062.x-BIB15","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1046\/j.1528-1157.2001.02101.x","article-title":"A pharmacoepidemiologic study of factors influencing the outcome of treatment with lamotrigine in chronic epilepsy","volume":"42","author":"Wong","year":"2001","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.2008.01062.x-BIB16","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.yebeh.2006.12.005","article-title":"Long-term retention rates of new antiepileptic drugs in adults with chronic epilepsy and learning disability","volume":"10","author":"Simister","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1111\/j.1600-0404.2008.01062.x-BIB17","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.seizure.2007.01.004","article-title":"Comparative retention rates and long-term tolerability of new antiepileptic drugs","volume":"16","author":"Chung","year":"2007","journal-title":"Seizure"},{"key":"10.1111\/j.1600-0404.2008.01062.x-BIB18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1059-1311(02)00251-0","article-title":"Efficacy and tolerability of levetiracetam during 1-year follow-up in patients with refractory epilepsy","volume":"12","author":"Ben Menachem","year":"2003","journal-title":"Seizure"},{"key":"10.1111\/j.1600-0404.2008.01062.x-BIB19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/jnnp.2005.064626","article-title":"The long term retention of levetiracetam in a large cohort of patients with epilepsy","volume":"77","author":"Depondt","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1600-0404.2008.01062.x-BIB20","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1212\/01.WNL.0000133214.78602.B3","article-title":"A prospective analysis of the outcome of levetiracetam in clinical practice","volume":"63","author":"Nicolson","year":"2004","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2008.01062.x-BIB21","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.yebeh.2004.03.002","article-title":"Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center","volume":"5","author":"Bootsma","year":"2004","journal-title":"Epilepsy Behav"},{"key":"10.1111\/j.1600-0404.2008.01062.x-BIB22","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1528-1157.2000.tb00165.x","article-title":"Prognostic factors affecting long-term retention of topiramate in patients with chronic epilepsy","volume":"41","author":"Lhatoo","year":"2000","journal-title":"Epilepsia"},{"key":"10.1111\/j.1600-0404.2008.01062.x-BIB23","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.yebeh.2006.03.007","article-title":"Long-term effects of tiagabine monotherapy on cognition and mood in adult patients with chronic partial epilepsy","volume":"8","author":"Aikia","year":"2006","journal-title":"Epilepsy Behav"},{"key":"10.1111\/j.1600-0404.2008.01062.x-BIB24","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1053\/seiz.2000.0433","article-title":"Safety of long-term treatment with tiagabine","volume":"9","author":"Fakhoury","year":"2000","journal-title":"Seizure"},{"key":"10.1111\/j.1600-0404.2008.01062.x-BIB25","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/01.wnf.0000159956.87511.67","article-title":"Meta-analysis and indirect comparisons of levetiracetam with other second-generation antiepileptic drugs in partial epilepsy","volume":"28","author":"Otoul","year":"2005","journal-title":"Clin Neuropharmacol"},{"key":"10.1111\/j.1600-0404.2008.01062.x-BIB26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-1211(02)00257-7","article-title":"Current limitations of antiepileptic drug therapy: a conference review","volume":"53","author":"Deckers","year":"2003","journal-title":"Epilepsy Res"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0404.2008.01062.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0404.2008.01062.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T05:05:13Z","timestamp":1709096713000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0404.2008.01062.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0404.2008.01062.x","relation":{},"ISSN":["0001-6314","1600-0404"],"issn-type":[{"value":"0001-6314","type":"print"},{"value":"1600-0404","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}